OGN vs VRT · P/E 3.4, rev $6.40B vs P/E 80, rev $10.23B
Organon & Co (OGN) versus Vertiv Holdings Co (VRT) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Vertiv Holdings Co (VRT) is a electrical equipment & parts company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported VRT revenue for 2025-12-31 was $10.23B. Net income was $1.33B. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
Not investment advice. Open the OGN and VRT stock pages for the full models.
Not investment advice.